Literature DB >> 32676921

Comment on "Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases".

Shu-Shan Zhao1, Wei-Min Li2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32676921     DOI： 10.1007/s10067-020-05295-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

Review 1.  The microbiome in autoimmune diseases.

Authors:  F De Luca; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

Review 2.  Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis.

Authors:  Peng Wang; Jin-Hui Tao; Hai-Feng Pan
Journal:  Inflammopharmacology       Date:  2016-08-31       Impact factor: 4.473

3.  Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis.

Authors:  Elnaz Vaghef-Mehrabany; Beitullah Alipour; Aziz Homayouni-Rad; Sakineh-Khatoon Sharif; Mohammad Asghari-Jafarabadi; Sema Zavvari
Journal:  Nutrition       Date:  2013-12-17       Impact factor: 4.008

4.  Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial.

Authors:  Beitullah Alipour; Aziz Homayouni-Rad; Elnaz Vaghef-Mehrabany; Sakineh Khatoun Sharif; Leila Vaghef-Mehrabany; Mohammad Asghari-Jafarabadi; Mohammad Reza Nakhjavani; Javad Mohtadi-Nia
Journal:  Int J Rheum Dis       Date:  2014-03-27       Impact factor: 2.454

5.  Human genetics shape the gut microbiome.

Authors:  Julia K Goodrich; Jillian L Waters; Angela C Poole; Jessica L Sutter; Omry Koren; Ran Blekhman; Michelle Beaumont; William Van Treuren; Rob Knight; Jordana T Bell; Timothy D Spector; Andrew G Clark; Ruth E Ley
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

6.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial.

Authors:  David R Mandel; Katy Eichas; Judith Holmes
Journal:  BMC Complement Altern Med       Date:  2010-01-12       Impact factor: 3.659
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.